ACB
Aurora Cannabis Inc.NASDAQHealthcare$3.44+2.69%ClosedMarket Cap: $195.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.51
P/S
0.75
EV/EBITDA
13.04
DCF Value
$-33.34
FCF Yield
-11.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.5%
Operating Margin
-1.2%
Net Margin
-11.7%
ROE
-7.8%
ROA
-5.5%
ROIC
-0.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $94.2M | 49.5% | $4.8M | $1.8M | $0.03 | — |
| Q2 2026 | $90.4M | 35.7% | $-15.7M | $-51.5M | $-0.91 | — |
| Q1 2026 | $88.2M | 89.6% | $36.9M | $31.7M | $-0.36 | — |
| Q4 2025 | $90.5M | 24.2% | $-30.4M | $-24.6M | $-0.44 | — |
| FY 2025 | $343.3M | 54.6% | $4.9M | $1.6M | $0.03 | — |
| Q3 2025 | $88.2M | 89.6% | $36.9M | $31.7M | $0.58 | — |
| Q2 2025 | $81.1M | 52.0% | $-2.4M | $-12.0M | $-0.22 | — |
| Q1 2025 | $83.4M | 53.4% | $877.0K | $6.5M | $0.13 | — |
| Q4 2024 | $67.4M | 75.9% | $3.1M | $-17.4M | $-0.26 | — |
| FY 2024 | $270.3M | 48.6% | $-46.5M | $-69.3M | $-1.28 | — |
| Q3 2024 | $64.4M | 38.8% | $-17.6M | $-17.0M | $-0.52 | — |
| Q2 2024 | $63.1M | 54.5% | $-10.8M | $-523.0K | $-0.01 | — |